Skip to main content

Companies researching CAR-T Cell Therapy

CAR‑T cell therapy engineers a patient's T cells to express chimeric antigen receptors, enabling them to identify and eliminate cancer cells, and is often classified as a cell‑based gene therapy.

List of companies that research CAR-T Cell Therapy

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Hospitals and Health Care

138k

$94B

CAR-T Cell Therapy

United States

Pharmaceutical Manufacturing

39k

$46B

CAR-T Cell Therapy

United Kingdom

Hospitals and Health Care

193k

$105B

CAR-T Cell Therapy

United States

Biotechnology Research

2.6k

$90M

CAR-T Cell Therapy

United States

Biotechnology Research

4.1k

$45M

CAR-T Cell Therapy

United States

Hospitals and Health Care

21k

$3.8B

CAR-T Cell Therapy

United States

Hospitals and Health Care

13k

$2.4B

CAR-T Cell Therapy

United States

Hospitals and Health Care

4.1k

$500M

CAR-T Cell Therapy

United Kingdom

Pharmaceutical Manufacturing

82k

CAR-T Cell Therapy

United States

Biotechnology Research

168

$2.9M

CAR-T Cell Therapy

Showing top companies out of 617 that research CAR-T Cell Therapy. Get the full list on TheirStack.

Frequently asked questions